Approval · Notice of Compliance 1701 · 2001
TRACLEER: Notice of Compliance 1701
Issued November 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1701
- Date
- November 30, 2001
- Company
- Actelion Pharmaceuticals LtdAllschwil, Basel-Landschaft, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Endothelin receptor antagonist